RxDoctor Payments Data

Kevin Graham, MD

Family Medicine · Granville, OHNPI 1457559692

Payments from drug & device makers

$2,206in general payments, 2019–2025

Across 137 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$605
  • Pfizer$324
  • Novo Nordisk$253
  • AstraZeneca$245
  • Astellas Pharma US Inc$157
  • Exact Sciences$97
  • plus $525 from 14 others

What the payments were for

  • Food & beverage$2,19199%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,206 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$146,703
Medicare patients
270
Services billed
3,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban102$116,253
OzempicSemaglutide101$107,814
JardianceEmpagliflozin45$54,081
JanuviaSitagliptin Phosphate38$46,181
TrulicityDulaglutide36$38,481
XareltoRivaroxaban35$37,444
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$36,713
FarxigaDapagliflozin Propanediol30$29,411
RybelsusSemaglutide23$23,593
ShingrixVaricella-Zoster Ge/As01b/Pf75$16,599
MounjaroTirzepatide14$14,672
JanumetSitagliptin Phos/Metformin Hcl11$14,641
Tresiba Flextouch U-100Insulin Degludec24$13,959
MyrbetriqMirabegron18$13,891
Breo ElliptaFluticasone/Vilanterol25$12,666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$253$131,407124 claims
PfizerEliquis$324$116,253102 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$46$75,043165 claims
MerckJanuvia, Janumet$29$60,82249 claims
Boehringer IngelheimJardiance$55$54,08145 claims
Lilly USA, LLCTrulicity, Mounjaro$47$53,15250 claims
AstraZenecaFarxiga, Breztri Aerosphere$245$38,49141 claims
Johnson & JohnsonXarelto$43$37,44435 claims
Astellas Pharma US IncMyrbetriq$157$13,89118 claims
AbbVieLinzess, Synthroid$605$8,50641 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Granville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →